Keyphrases
Colorectal Cancer
100%
Chromosomal Instability
100%
P53 Expression
100%
T Antigen
100%
CpG Island Methylator Phenotype
100%
JC Virus
100%
Adjusted Odds Ratio
50%
Catenin
25%
Antigen Expression
16%
LINE-1 Hypomethylation
16%
Microsatellite Instability-high (MSI-H)
16%
Cell Proliferation
8%
DNA Methylation (DNAm)
8%
Insulin-like Growth Factor Binding protein-3 (IGFBP-3)
8%
Immunohistochemistry
8%
Colon Cancer
8%
Multivariate Analysis
8%
Molecular Alterations
8%
Cyclin D1 (CCND1)
8%
Mgmt
8%
Patient Survival
8%
Logistic Regression Analysis
8%
Insulin-like Growth Factor 2 (IGF2)
8%
Loss of Heterozygosity
8%
BRAF mutation
8%
MLH1
8%
Cyclooxygenase-2 Expression
8%
Wild-type p53
8%
SOCS1
8%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
8%
Specific Promoter
8%
Neurog1
8%
Runt-related Transcription Factor 3 (RUNX3)
8%
Clinical Prognosis
8%
CRABP1
8%
PIK3CA mutation
8%
Mint1
8%
HIC1
8%
Transforming Genes
8%
Chfr
8%
CACNA1G
8%
MethyLight
8%
Clinical Outcomes
8%
Family History of Colorectal Cancer
8%
Immunology and Microbiology
JC Virus
100%
Chromosomal Instability
100%
Virus T Antigen
100%
P53
100%
CpG Island
100%
Colorectal Carcinoma
100%
Catenin
25%
Antigen Expression
16%
Microsatellite Instability
16%
Colon
8%
Cell Proliferation
8%
Promoter Region
8%
Cyclin D1
8%
Heterozygosity
8%
DNA Methylation
8%
Wild Type
8%
Oncogene
8%
Cyclooxygenase
8%
Biochemistry, Genetics and Molecular Biology
Chromosome Instability
100%
P53
100%
CpG Island
100%
JC Virus
100%
Catenin
25%
Microsatellite Instability
16%
Antigen Expression
16%
Oncogene
8%
Colon
8%
Multivariate Analysis
8%
Wild Type
8%
IGFBP3
8%
Loss of Heterozygosity
8%
MLH1
8%
DNA Methylation
8%
Promoter Region
8%
Cell Proliferation
8%
P21
8%
RUNX3
8%
HIC1
8%
Cyclooxygenase
8%
Cyclin D1
8%
Cyclin Dependent Kinase Inhibitor 2A
8%